Reblogged from Science on the Net
Through the years and the development of pharmacology, Antimicrobial resistance (AMR) is a growing public health threat of broad concern to countries. Recently, the World Health Organization (WHO) produced a global report on surveillance of antimicrobial resistance in collaboration with Member States. This report monitors the situation worldwide, showing that the percentage of antibiotic resistance to various diseases is growing year after year all over the world, especially in developed countries, and the resistance to common bacteria has reached alarming levels in many parts of the world. It indicates that many of the available treatment options for common infections in some settings are becoming ineffective.
According to those who prepared the report, “a post-antibiotic era—in which common infections and minor injuries can kill—far from being an apocalyptic fantasy, is instead a very real possibility for the 21st century.”
Particularly, the report focuses on antibacterial resistance (ABR), which involves bacteria that causes many common infections for which treatment is becoming difficult. The main focus of this report is therefore on ABR for which knowledge, support and concerted action are inadequate. The report considers seven types of antibacterial resistance pathologies and their respective drug treatments:
– Escherichia Coli vs. the third-generation Cephalosporins and vs. Fluoroquinolones
– Kleibsiella Pneumoniae vs. the third-generation Cephalosporins and vs. Carbapenems
– Staphylococcus Aureus vs. Methiccilin
– Strptococcus Pneumoniae vs. Penicillin
– Non Typhoidal Salmonella vs. Fluoroquinolones
– Shigella Species vs. Fluoroquinolones
– Neisseria Gonorrhoeae vs. 3rd generation Cephalosporins
